GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius Stedim Biotech SA (XPAR:DIM) » Definitions » Cyclically Adjusted PB Ratio

Sartorius Stedim Biotech (XPAR:DIM) Cyclically Adjusted PB Ratio : 14.13 (As of Apr. 27, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Sartorius Stedim Biotech Cyclically Adjusted PB Ratio?

As of today (2024-04-27), Sartorius Stedim Biotech's current share price is €208.30. Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €14.74. Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio for today is 14.13.

The historical rank and industry rank for Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio or its related term are showing as below:

XPAR:DIM' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 11.68   Med: 19.9   Max: 37.1
Current: 13.8

During the past years, Sartorius Stedim Biotech's highest Cyclically Adjusted PB Ratio was 37.10. The lowest was 11.68. And the median was 19.90.

XPAR:DIM's Cyclically Adjusted PB Ratio is ranked worse than
95.39% of 456 companies
in the Medical Devices & Instruments industry
Industry Median: 2.11 vs XPAR:DIM: 13.80

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sartorius Stedim Biotech's adjusted book value per share data for the three months ended in Dec. 2023 was €28.621. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €14.74 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Chart

Sartorius Stedim Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 25.02 16.25

Sartorius Stedim Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.02 21.73 17.01 15.95 16.25

Competitive Comparison of Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio

For the Medical Instruments & Supplies subindustry, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio falls into.



Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=208.30/14.74
=14.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sartorius Stedim Biotech's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sartorius Stedim Biotech's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=28.621/123.6675*123.6675
=28.621

Current CPI (Dec. 2023) = 123.6675.

Sartorius Stedim Biotech Quarterly Data

Book Value per Share CPI Adj_Book
201012 3.576 94.132 4.698
201106 3.634 95.158 4.723
201112 4.284 95.998 5.519
201206 4.405 96.744 5.631
201212 4.228 97.957 5.338
201306 4.395 98.516 5.517
201312 4.678 99.356 5.823
201406 4.770 99.543 5.926
201412 5.778 99.543 7.178
201506 6.317 100.417 7.780
201512 6.957 99.717 8.628
201606 7.278 100.717 8.936
201612 8.223 101.217 10.047
201706 8.644 102.117 10.468
201709 0.000 102.717 0.000
201712 9.460 102.617 11.401
201803 0.000 102.917 0.000
201806 9.951 104.017 11.831
201809 10.497 104.718 12.397
201812 11.243 104.217 13.341
201903 11.356 104.217 13.475
201906 11.924 105.718 13.949
201909 12.670 106.018 14.779
201912 12.571 105.818 14.692
202003 13.309 105.718 15.569
202006 13.657 106.618 15.841
202009 14.615 105.818 17.080
202012 15.601 105.518 18.285
202103 16.608 107.518 19.103
202106 18.101 108.486 20.634
202109 18.099 109.435 20.453
202112 17.964 110.384 20.126
202203 20.866 113.968 22.642
202206 22.260 115.760 23.780
202209 24.660 118.818 25.667
202212 26.575 119.345 27.538
202303 26.261 122.402 26.532
202306 27.879 123.140 27.998
202309 28.153 124.195 28.034
202312 28.621 123.668 28.621

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sartorius Stedim Biotech  (XPAR:DIM) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sartorius Stedim Biotech Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sartorius Stedim Biotech's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sartorius Stedim Biotech (XPAR:DIM) Business Description

Address
Otto-Brenner-Strasse 20, Goettingen, DEU, 37079
Sartorius Stedim Biotech, or SSB, is a leading provider of bioprocessing solutions. Its sells equipment and consumables for fermentation, filtration, fluid management, purification, and cell culture media for manufacturing biologic drugs, and has a focus on single-use technology, or SUT. It is a subsidiary of Sartorius AG, which has a 74% ownership and 85% voting control. The business is geographically diverse.

Sartorius Stedim Biotech (XPAR:DIM) Headlines